Market Insider

Rivian electric pickup trucks sit in a parking lot at a Rivian service center on May 09, 2022 in South San Francisco, California. 
Justin Sullivan | Getty Images

Check out the companies making headlines after hours.

Rivian — Shares of the electric vehicle maker increased 2.7% after announcing after the bell that production met expectations in its quarter ending Sept. 30.

Dynatrace — The software intelligence company jumped 4.6% after being upgraded to a buy from JPMorgan. Earlier, the stock rose 3% during regular trading.

Kezar Life Sciences — Shares of the biotechnology company were up 2.3% after it announced FDA clearance of its investigational new drug application for an autoimmune hepatitis treatment.

Rocket Pharmaceuticals — The stock dropped 4.6% after the company started a $100 million secondary. Underwriters have a 30-day option to purchase up to $15 million in additional shares.

Articles You May Like

Alibaba’s Risky Gamble: Can the E-Commerce Titan Bounce Back from Its Missteps?
3 EV Stocks to Buy for 10-Bagger Returns by 2030: April Edition
Ford Stock Earnings Preview: You’ll Be Crying if You’re Not Buying
Analysts are Wrong, JD.com Is a Hidden Gem: Inside the Chinese Titan’s Explosive Growth and Dirt-Cheap Valuation
The Top 3 Semiconductor Stocks to Buy in April 2024